196 related articles for article (PubMed ID: 28030819)
21. 6,8-Diprenylorobol Induces Apoptosis in Human Hepatocellular Carcinoma Cells via Activation of FOXO3 and Inhibition of CYP2J2.
Lee CM; Lee J; Jang SN; Shon JC; Wu Z; Park K; Liu KH; Park SH
Oxid Med Cell Longev; 2020; 2020():8887251. PubMed ID: 33312341
[TBL] [Abstract][Full Text] [Related]
22. Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells.
Zhang D; Chen Y; Xie X; Liu J; Wang Q; Kong W; Zhu Y
J Mol Cell Cardiol; 2012 Oct; 53(4):487-96. PubMed ID: 22867875
[TBL] [Abstract][Full Text] [Related]
23. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C
Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144
[TBL] [Abstract][Full Text] [Related]
24. Effects of cytochrome P450 arachidonic acid epoxygenases on the proliferation of tumor cells.
Jiang JG; Shen GF; Chen C; Fu XN; Wang DW
Ai Zheng; 2009 Jan; 28(1):14-9. PubMed ID: 19448409
[TBL] [Abstract][Full Text] [Related]
25. NMI promotes hepatocellular carcinoma progression via BDKRB2 and MAPK/ERK pathway.
Zhao J; Dong QZ; Zhong F; Cai LL; Qin ZY; Liu Y; Lin CZ; Qin LX; He FC
Oncotarget; 2017 Feb; 8(7):12174-12185. PubMed ID: 28077802
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma.
Sheng SL; Liu JJ; Dai YH; Sun XG; Xiong XP; Huang G
FEBS J; 2012 Oct; 279(20):3898-910. PubMed ID: 22897481
[TBL] [Abstract][Full Text] [Related]
27. Let-7b inhibits human cancer phenotype by targeting cytochrome P450 epoxygenase 2J2.
Chen F; Chen C; Yang S; Gong W; Wang Y; Cianflone K; Tang J; Wang DW
PLoS One; 2012; 7(6):e39197. PubMed ID: 22761738
[TBL] [Abstract][Full Text] [Related]
28. CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα
He Z; Yang Y; Wen Z; Chen C; Xu X; Zhu Y; Wang Y; Wang DW
J Lipid Res; 2017 Jul; 58(7):1338-1353. PubMed ID: 28554983
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-107: a novel promoter of tumor progression that targets the CPEB3/EGFR axis in human hepatocellular carcinoma.
Zou CD; Zhao WM; Wang XN; Li Q; Huang H; Cheng WP; Jin JF; Zhang H; Wu MJ; Tai S; Zou CX; Gao X
Oncotarget; 2016 Jan; 7(1):266-78. PubMed ID: 26497556
[TBL] [Abstract][Full Text] [Related]
30. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma.
Liu WR; Tian MX; Yang LX; Lin YL; Jin L; Ding ZB; Shen YH; Peng YF; Gao DM; Zhou J; Qiu SJ; Dai Z; He R; Fan J; Shi YH
Oncotarget; 2015 Jan; 6(2):846-61. PubMed ID: 25514599
[TBL] [Abstract][Full Text] [Related]
31. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
Satow R; Shitashige M; Kanai Y; Takeshita F; Ojima H; Jigami T; Honda K; Kosuge T; Ochiya T; Hirohashi S; Yamada T
Clin Cancer Res; 2010 May; 16(9):2518-28. PubMed ID: 20388846
[TBL] [Abstract][Full Text] [Related]
32. The histone demethylase JMJD1A regulates adrenomedullin-mediated cell proliferation in hepatocellular carcinoma under hypoxia.
Park SJ; Kim JG; Son TG; Yi JM; Kim ND; Yang K; Heo K
Biochem Biophys Res Commun; 2013 May; 434(4):722-7. PubMed ID: 23583388
[TBL] [Abstract][Full Text] [Related]
33. Aryl hydrocarbon receptor nuclear translocator is associated with tumor growth and progression of hepatocellular carcinoma.
Liang Y; Li WW; Yang BW; Tao ZH; Sun HC; Wang L; Xia JL; Qin LX; Tang ZY; Fan J; Wu WZ
Int J Cancer; 2012 Apr; 130(8):1745-54. PubMed ID: 21544813
[TBL] [Abstract][Full Text] [Related]
34. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.
Li R; Xu X; Chen C; Wang Y; Gruzdev A; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E270-82. PubMed ID: 25389363
[TBL] [Abstract][Full Text] [Related]
35. CHD5 a tumour suppressor is epigenetically silenced in hepatocellular carcinoma.
Zhao R; Wang N; Huang H; Ma W; Yan Q
Liver Int; 2014 Jul; 34(6):e151-60. PubMed ID: 24529164
[TBL] [Abstract][Full Text] [Related]
36. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
Xu Q; Cai W; Zhang M; Liu Q; Liu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar; 32(3):387-92. PubMed ID: 26927562
[TBL] [Abstract][Full Text] [Related]
37. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
38. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
39. MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1.
Yan JJ; Zhang YN; Liao JZ; Ke KP; Chang Y; Li PY; Wang M; Lin JS; He XX
Oncotarget; 2015 Oct; 6(30):29527-42. PubMed ID: 26336827
[TBL] [Abstract][Full Text] [Related]
40. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
